Physician profile
Laura Dirig
NPI 1063931137
$1,696.13
in general payments reported to CMS, 2019-2025
17 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $815 · 2022: $498 · 2023: $359 · 2024: $23.68.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $383.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $382.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $665.02 | 2021-2024 | |
| Exeltis, USA INC. | $229.00 | 2021-2023 | Slynd |
| Astellas Pharma US INC | $125.00 | 2023 | Veozah |
| Myovant Sciences INC. | $124.99 | 2021-2022 | |
| Mayne Pharma Commercial LLC | $104.09 | 2021-2023 | |
| Bayer Healthcare Pharmaceuticals INC. | $94.45 | 2021-2022 | |
| Amgen INC. | $62.53 | 2021-2022 | |
| Therapeuticsmd, INC. | $52.00 | 2022 | |
| Organon LLC | $43.38 | 2021-2022 | |
| Avion Pharmaceuticals | $37.97 | 2021-2022 | |
| Exact Sciences Corporation | $34.99 | 2023 | Cologuard Collection Kit |
| Mylan Pharmaceuticals INC. | $29.68 | 2022 | |
| Axonics, INC. | $28.26 | 2023 | Axonics, Bulkamid |
| Daiichi Sankyo INC. | $24.86 | 2021 | |
| Scynexis, INC. | $17.08 | 2022 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coopersurgical, INC. | $11.75 | 2021 | |
| Pfizer INC. | $11.08 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Laura Dirig listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.